Get the Stockscreener App
308.10
0.93%
-2.90
Evercore Inc stock is traded at $308.10, with a volume of 159.32K.
It is down -0.93% in the last 24 hours and up +18.24% over the past month.
Evercore is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,200 employees at the end of 2023, and about 75% of its revenue is derived from the United States.
See More
Previous Close:
$311.00
Open:
$313.7
24h Volume:
159.32K
Relative Volume:
0.51
Market Cap:
$11.71B
Revenue:
$2.79B
Net Income/Loss:
$320.59M
P/E Ratio:
39.75
EPS:
7.75
Net Cash Flow:
$714.18M
1W Performance:
+2.26%
1M Performance:
+18.24%
6M Performance:
+50.72%
1Y Performance:
+109.09%
1-Day Range:
$306.87
$314.82
1-Week Range:
$302.16
$317.30
52-Week Range:
$146.02
$324.06
Evercore Inc Stock (EVR) Company Profile
Name
Evercore Inc
Sector
Industry
Phone
212-857-3100
Address
55 EAST 52ND STREET, NEW YORK, NY
Compare EVR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVR
Evercore Inc
|
308.10 | 11.71B | 2.79B | 320.59M | 714.18M | 7.75 |
|
MS
Morgan Stanley
|
131.21 | 211.42B | 54.61B | 11.19B | -31.70B | 5.58 |
|
GS
Goldman Sachs Group Inc
|
605.43 | 190.77B | 50.96B | 12.17B | -90.39B | 20.66 |
|
SCHW
Charles Schwab Corp
|
82.60 | 150.69B | 18.74B | 5.15B | 33.11B | 3.00 |
|
HOOD
Robinhood Markets Inc
|
37.65 | 33.02B | 2.41B | 525.00M | 2.16B | -0.93 |
|
TW
Tradeweb Markets Inc
|
136.04 | 29.08B | 1.63B | 448.61M | 797.37M | 1.72 |
Evercore Inc Stock (EVR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-24 | Initiated | Wells Fargo | Equal Weight |
| Sep-11-24 | Upgrade | Goldman | Neutral → Buy |
| Jan-29-24 | Resumed | Keefe Bruyette | Mkt Perform |
| Jan-09-24 | Downgrade | UBS | Buy → Neutral |
| Aug-22-23 | Downgrade | Goldman | Buy → Neutral |
| Apr-12-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-12-23 | Upgrade | UBS | Sell → Buy |
| Jan-11-23 | Upgrade | Goldman | Neutral → Buy |
| Oct-27-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Sep-23-22 | Downgrade | UBS | Neutral → Sell |
| Jan-06-22 | Downgrade | Goldman | Buy → Neutral |
| Dec-08-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-04-21 | Downgrade | UBS | Buy → Neutral |
| Apr-09-21 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Mar-19-21 | Reiterated | Goldman | Buy |
| Jan-05-21 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-16-20 | Initiated | Seaport Global Securities | Buy |
| Dec-01-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Oct-02-20 | Upgrade | UBS | Neutral → Buy |
| Aug-05-20 | Upgrade | Goldman | Neutral → Buy |
| Jul-09-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-25-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-06-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Nov-20-19 | Initiated | Morgan Stanley | Overweight |
| Aug-14-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-06-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-23-19 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jan-07-19 | Downgrade | Goldman | Neutral → Sell |
| Nov-06-18 | Initiated | Goldman | Neutral |
| Jan-09-18 | Upgrade | UBS | Neutral → Buy |
| May-23-17 | Downgrade | Goldman | Buy → Neutral |
| Mar-27-17 | Initiated | Keefe Bruyette | Mkt Perform |
| Feb-16-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-13-17 | Downgrade | Instinet | Buy → Neutral |
| Dec-14-16 | Initiated | BofA/Merrill | Neutral |
| Nov-21-16 | Resumed | Credit Suisse | Outperform |
View All
Evercore Inc Stock (EVR) Latest News
Analog Devices, Inc. (ADI): Evercore ISI Ups Price Target to $280, Predicts Demand Rebound - Insider Monkey
Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
Evercore ISI Group Downgrades CBRE Group (CBRE) - MSN
Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - PR Newswire
Apellis Pharmaceuticals to Present at Evercore ISI and Citi Healthcare Conferences | APLS Stock News - StockTitan
Perspective Therapeutics to Present at Piper and Evercore Healthcare Conferences in December | CATX Stock News - StockTitan
Evercore bullish on Fluence stock despite lowered target, highlights growth potential - Investing.com
Burlington Stores (BURL) PT Raised to $340 at Evercore ISI - StreetInsider.com
Nordstrom (JWN) PT Raised to $22 at Evercore ISI - StreetInsider.com
Evercore ISI Group Upgrades Zoom Video Communications (ZM) - MSN
Umoja Biopharma to Present at the 7th Annual Evercore ISI HealthCONx Conference - GlobeNewswire
Danaher to Present at Evercore ISI HealthCONx Conference - Marketscreener.com
Danaher CEO to Present at Evercore ISI HealthCONx Conference in 2024 | DHR Stock News - StockTitan
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference - GlobeNewswire
Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference - The Manila Times
89bio to Participate in the 7th Annual Evercore HealthCONx Conference - The Manila Times
Fortrea to Present at the Evercore HealthCONx Conference - Yahoo Finance
Dynavax Technologies to Present at Evercore HealthCONx Conference | DVAX Stock News - StockTitan
Waystar CEO to Present at Evercore and Barclays Healthcare Tech Conferences | WAY Stock News - StockTitan
Kiniksa Pharmaceuticals to Present at Evercore ISI HealthCONx Conference | KNSA Stock News - StockTitan
Acumen Pharmaceuticals to Present Alzheimer's Treatment Progress at Evercore Conference | ABOS Stock News - StockTitan
Evercore upgrades Zoom to ‘outperform’ as its reinvention gains momentum By Investing.com - Investing.com Canada
Avidity Biosciences to Present at Evercore ISI HealthCONx Conference | RNA Stock News - StockTitan
Evercore upgrades Zoom to ‘outperform’ as its reinvention gains momentum - Investing.com India
Wave Life Sciences CEO to Present at Evercore and Citi Healthcare Conferences | WVE Stock News - StockTitan
Aura Biosciences CEO to Present at Evercore ISI HealthCONx Conference | AURA Stock News - StockTitan
Zoom Video Communications (NASDAQ:ZM) Stock Rating Upgraded by Evercore ISI - MarketBeat
Rallybio to Present at the 2024 Evercore ISI HealthCONx Conference - Business Wire
Altimmune to Present at Evercore and Piper Sandler Healthcare Conferences in December | ALT Stock News - StockTitan
Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference - The Manila Times
SpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - The Manila Times
SpringWorks Therapeutics to Present at Evercore ISI HealthCONx Conference | SWTX Stock News - StockTitan
ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference - Kirkland Lake Northern News
Nkarta to Present NK Cell Therapy Advances at Evercore HealthCONx Conference | NKTX Stock News - StockTitan
Atea Pharmaceuticals to Present and Provide a Business Update at the 7th Annual Evercore HealthCONx Conference - Yahoo Finance
Avantor, Inc. CEO to Speak at Evercore ISI HealthCONx Conference - MSN
Teva CEO to Present at Evercore ISI HealthCONx Conference: Key Updates Expected | TEVA Stock News - StockTitan
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference - Yahoo Finance
Spyre Therapeutics to Present at Evercore ISI HealthCONx Conference | IBD Treatment Updates | SYRE Stock News - StockTitan
Third Harmonic Bio to Present at Evercore HealthCONx Conference in December | THRD Stock News - StockTitan
Soaring legal fees in snarled Citgo auction rankle companies - Marketscreener.com
Evercore ISI Boosts CrowdStrike (NASDAQ:CRWD) Price Target to $400.00 - MarketBeat
CrowdStrike Shares Decline Despite Evercore Raising Price Target on Channel Check Insights - GuruFocus.com
CrowdStrike slips even as Evercore ups target on strong channel checks (CRWD) - Seeking Alpha
Marsh & McLennan stock gains momentum as Evercore highlights acquisition synergies - Investing.com India
Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Marketscreener.com
Vir Biotechnology CEO to Present at Evercore ISI HealthCONx Conference | VIR Stock News - StockTitan
Marsh & McLennan Companies' (MMC) "Outperform" Rating Reiterated at Evercore ISI - MarketBeat
Coya Therapeutics to Present at Evercore HealthCONx Conference in December | COYA Stock News - StockTitan
Contineum Therapeutics to Present at Evercore HealthCONx Conference 2024 | CTNM Stock News - StockTitan
Evercore Inc Stock (EVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):